For those considering or currently using compounded GLP-1 medications, the question of how long to stay on them is a common concern
The medication reduces LDL (bad) cholesterol by 515%, increases HDL (good) cholesterol, and lowers triglycerides by up to 20% in many patients
In phase 2 clinical trials published in the New England Journal of Medicine (2023), it demonstrated substantial weight loss outcomes, largely attributed to its ability to influence hunger signals particularly in the hypothalamus, which governs satiety and energy balance
The main agents currently approved by the EMA and/or FDA include exenatide (2005/2005), liraglutide (2009/2010), lixisenatide (2013/2016), dulaglutide (2014/2014), semaglutide (2017/2017
Experience the transformative effects of Cryo Slimming in Riverview